Primarily through its antioxidant, anti-inflammatory, and glutamate modulation activity, NAC has been investigated in the treatment of neurodevelopmental disorders, schizophrenia spectrum disorders, bipolar-related disorders, depressive disorders, anxiety disorders, obsessive compulsive-related disorders, substance-use disorders, neurocognitive disorders, and chronic pain
In combined studies, researchers explore models involving: Growth-factor response coordination Angiogenic signaling integration Protein synthesis and turnover modulation Cellular migration and organizational processes These mechanisms are theoretical and based on early scientific literature rather than confirmed clinical effects
This includes patients with a known copper allergy or Wilsons disease (a genetic copper overload disorder)
What we do know is that topical glutathione appears to work best as part of combination therapy